Mostra i principali dati dell'item
Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: An evidence-based review
dc.creator | Giannaki, C. D. | en |
dc.creator | Hadjigeorgiou, G. M. | en |
dc.creator | Karatzaferi, C. | en |
dc.creator | Pantzaris, M. C. | en |
dc.creator | Stefanidis, I. | en |
dc.creator | Sakkas, G. K. | en |
dc.date.accessioned | 2015-11-23T10:27:55Z | |
dc.date.available | 2015-11-23T10:27:55Z | |
dc.date.issued | 2014 | |
dc.identifier | 10.1038/ki.2013.394 | |
dc.identifier.issn | 852538 | |
dc.identifier.uri | http://hdl.handle.net/11615/27849 | |
dc.description.abstract | Restless legs syndrome (RLS) (or Willis-Ekbom disease) is a neurological disorder with high prevalence among the end-stage renal disease population. This is one of the most predominant types of secondary RLS, and it is called uremic RLS. Despite the fact that uremic RLS has been less studied compared to idiopathic RLS, recent studies now shed light in many aspects of the syndrome including clinical characteristics, impact, epidemiology, and treatment options. The current review discusses the above topics with special emphasis given on the management of uremic RLS, including the management of symptoms that often appear during a hemodialysis session. Uremic RLS symptoms may be ameliorated by using pharmacological and nonpharmacological treatments. Evidence so far shows that both approaches may be effective in terms of reducing the RLS symptom's severity; nevertheless, more research is needed on the efficiency of treatments for uremic RLS. © 2014 International Society of Nephrology. | en |
dc.source.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-84901932025&partnerID=40&md5=87c0a33daa89b9df971112658734a0a4 | |
dc.subject | dopamine agonists | en |
dc.subject | exercise | en |
dc.subject | hemodialysis | en |
dc.subject | quality of life | en |
dc.subject | secondary RLS | en |
dc.subject | sleep disorders | en |
dc.subject | clonazepam | en |
dc.subject | dopamine receptor stimulating agent | en |
dc.subject | erythropoietin | en |
dc.subject | gabapentin | en |
dc.subject | iron dextran | en |
dc.subject | levodopa | en |
dc.subject | pergolide | en |
dc.subject | placebo | en |
dc.subject | pramipexole | en |
dc.subject | ropinirole | en |
dc.subject | rotigotine | en |
dc.subject | talipexole | en |
dc.subject | absence of side effects | en |
dc.subject | actimetry | en |
dc.subject | aerobic exercise | en |
dc.subject | bedtime dosage | en |
dc.subject | differential diagnosis | en |
dc.subject | disease severity | en |
dc.subject | drug dose increase | en |
dc.subject | drug efficacy | en |
dc.subject | end stage renal disease | en |
dc.subject | family history | en |
dc.subject | headache | en |
dc.subject | human | en |
dc.subject | International RLS Study Group questionnaire | en |
dc.subject | kidney transplantation | en |
dc.subject | lethargy | en |
dc.subject | mortality | en |
dc.subject | nausea | en |
dc.subject | nightmare | en |
dc.subject | pathophysiology | en |
dc.subject | periodic limb movement disorder | en |
dc.subject | polysomnography | en |
dc.subject | prevalence | en |
dc.subject | priority journal | en |
dc.subject | questionnaire | en |
dc.subject | restless legs syndrome | en |
dc.subject | review | en |
dc.subject | skeletal muscle | en |
dc.subject | sleep parameters | en |
dc.subject | somnolence | en |
dc.subject | symptom | en |
dc.subject | therapy effect | en |
dc.subject | vomiting | en |
dc.subject | weakness | en |
dc.subject | Wegener granulomatosis | en |
dc.subject | cost of illness | en |
dc.subject | evidence based medicine | en |
dc.subject | health status | en |
dc.subject | Kidney Failure, Chronic | en |
dc.subject | predictive value | en |
dc.subject | renal replacement therapy | en |
dc.subject | treatment outcome | en |
dc.subject | uremia | en |
dc.subject | Diagnosis, Differential | en |
dc.subject | Evidence-Based Medicine | en |
dc.subject | Humans | en |
dc.subject | Predictive Value of Tests | en |
dc.subject | Renal Dialysis | en |
dc.title | Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: An evidence-based review | en |
dc.type | journalArticle | en |
Files in questo item
Files | Dimensione | Formato | Mostra |
---|---|---|---|
Nessun files in questo item. |